Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of switching maraviroc for NNRTI or protease inhibitor in virologically suppressed HIV-1 patients with antiretroviral-related dyslipidemia
2009-011868-11Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of maraviroc in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoint: Virological failure at week 48. Started Apr 2009; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-011868-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011868-11.